PATENT CLAIM ANALYSIS

Application Number: 15769713
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "417000"]

Abstract:
Methods of treating immune reconstitution inflammatory syndrome (IRIS) in immunodeficient patients, including HIV patients, using PDE4 modulators are described.

Claim (Index 47):
The PDE4 modulator for use of  claim 46 , wherein said second active agent is a non-steroidal anti-inflammatory drug, a corticosteroid, an antimicrobial agent, an anti-fungal agent, or an anti-tuberculosis agent.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 91.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10534325', '10531552', '10392195', '10515270', '10794931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7258709446876747
- 35 USC 102 Novelty (BERT): 0.4981759453353842
- Combined Prediction Score: 0.7031014447524456
- Mean Citation Score: 179.10226400000005
- Max Citation Score: 196.59668
- Similarity Product: 135.896264962275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test